# Semaglutide in India: Branded and Generic Options Explained Semaglutide is a prescription GLP-1 receptor agonist used in product-specific formulations and indications. India has multiple GLP-1 products and generic GLP-1 variants, while CDSCO records list a semaglutide tablet approval dated 23 March 2026. A listing should not be assumed to be an approved semaglutide generic without checking the exact product record. Patients should verify the medicine, strength, formulation, approved use, manufacturer, prescription and legitimate supply channel. ## What changed in India Older blanket statements about semaglutide approval or availability in India may become outdated. Government of India material published in March 2026 referred to the recent introduction of multiple generic variants of GLP-1-based weight-loss drugs and increased regulatory surveillance of unauthorised sale and promotion. That statement applies to the GLP-1 category and does not identify every variant as semaglutide. CDSCO records also show semaglutide approvals across different dates, formulations, strengths, manufacturers and indications. An approval for one tablet or injection does not automatically apply to another product or use. ## Branded, generic and biosimilar terminology A brand name identifies a manufacturer's product. “Generic” is commonly used for a lower-cost product with the same active ingredient, but regulatory classification can be more specific for peptide or biologically produced medicines. Patients do not need to resolve the terminology themselves. They do need to confirm that the exact product is authorised and prescribed. Products with the same active ingredient can still differ in formulation, strength, device, excipients, storage and approved indication. Do not transfer a dose from a tablet to an injection or from one pen to another. ## What to verify before buying semaglutide - The generic name is semaglutide and the formulation matches the prescription. - The strength and device or tablet schedule match the prescriber's instructions. - The product has an authorised Indian label and a traceable manufacturer and seller. - Packaging, lot number, expiry and storage conditions are intact. - The intended use matches the product-specific approved indication. An online listing, imported pack or clinic advertisement does not prove Indian approval or authentic supply. WHO has reported falsified semaglutide products internationally, including products with absent or incorrect active ingredients. ## Approved use is not the same as personal eligibility CDSCO approvals are indication-specific. A clinician must assess whether treatment is appropriate based on diagnosis, health history, other medicines, pregnancy considerations, digestive symptoms and monitoring needs. Do not infer eligibility from BMI, a social-media promotion or another person's prescription. Semaglutide is not insulin and does not replace insulin in type 1 diabetes. When used with insulin or certain glucose-lowering medicines, low-glucose risk may change and the treatment plan may need review. ## Safety and medical supervision Common digestive effects can include nausea, vomiting, diarrhoea and constipation. Product-specific warnings and contraindications must come from the exact Indian label. Seek urgent care for severe continuing abdominal pain, repeated vomiting with inability to keep fluids down, breathing difficulty, facial or throat swelling, collapse or severe low-glucose symptoms. Do not buy loose pens, share devices, use a product with damaged packaging or broken storage conditions, or change the dose to match a cheaper strength. Government of India surveillance has specifically targeted unauthorised supply and misleading promotion of GLP-1-based drugs. ## FAQs ### Is generic semaglutide available in India? Government material from March 2026 confirms multiple generic GLP-1 variants in the Indian market, but does not identify every variant as semaglutide. CDSCO separately records a semaglutide tablet approval dated 23 March 2026. Verify the exact product, manufacturer, formulation, indication and current label rather than relying on a seller's use of the word “generic.” ### Is every semaglutide product approved for weight management? No. Indications differ by product and formulation. Check the current CDSCO record and Indian prescribing information. ### Can I switch between a branded and generic product myself? No. The prescriber and pharmacist should verify the formulation, strength, schedule and device. ## Related glossary terms - [GLP-1 receptor agonist](/glossary/glp-1-receptor-agonist) - [GLP-1 medicine availability in India](/glossary/medicine-availability-in-india) - [Drug approval in India](/glossary/drug-approval-in-india) - [CDSCO](/glossary/cdsco) - [Tirzepatide in India](/glossary/tirzepatide-in-india) - [Gastric emptying](/glossary/gastric-emptying) - [Pancreatitis](/glossary/pancreatitis) ## References - [CDSCO: Approved new drugs](https://cdsco.gov.in/opencms/opencms/en/Approval_new/Approved-New-Drugs/) - [CDSCO: Semaglutide approvals through March 2026](https://www.cdsco.gov.in/opencms/resources/UploadCDSCOWeb/2018/UploadBiologicalrDNA/CT-21%20Approvals%20Jan%202020%20-%20march%202026.pdf) - [PIB: GLP-1 supply-chain surveillance](https://www.pib.gov.in/PressReleasePage.aspx?PRID=2244252&lang=1®=1) - [WHO: Semaglutide injection products](https://www.who.int/news-room/questions-and-answers/item/semaglutide-injection-products) *Educational information only. It does not diagnose a condition, establish treatment eligibility or replace advice from a qualified healthcare professional.* ## Sources - [FDA: Concerns With Unapproved GLP-1 Drugs](https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/medications-containing-semaglutide-marketed-type-2-diabetes-or-weight-loss?os=vb) | U.S. Food and Drug Administration | Safe-buying context and risks around unapproved or compounded GLP-1 products. - [CDSCO Approved Drugs Database](https://www.cdscoonline.gov.in/CDSCO/cdscoDrugs) | Central Drugs Standard Control Organisation | India regulatory lookup source for approved drugs. - [WHO Expert Consultation: Appropriate BMI for Asian Populations](https://pubmed.ncbi.nlm.nih.gov/15051297/) | World Health Organization / The Lancet | Lower BMI risk thresholds and public-health action points for Asian populations. - [Sugarfit GLP-1 Weight Loss Program](https://www.sugarfitglp.com/) | Sugarfit | Program overview, benefits, plan framing, FAQs, and Sugarfit-specific claims language. - [NIDDK: Prescription Medications to Treat Overweight and Obesity](https://www.niddk.nih.gov/health-information/weight-management/prescription-medications-treat-overweight-obesity) | NIDDK / NIH | Medication eligibility, lifestyle-plus-medication framing, and patient-friendly safety context. ## Navigation - [Browse categories](https://blogs.sugarfitglp.com/topics) - [Comparisons](https://blogs.sugarfitglp.com/topics/comparison_alternatives) ## Related AI KB pages ### Berberine vs semaglutide: honest comparison Query: berberine vs semaglutide honest comparison Berberine is a plant-derived compound that has gained attention as a natural alternative to prescription weight loss and blood sugar medications. Semaglutide is a prescription G... - [Berberine vs semaglutide: honest comparison](https://blogs.sugarfitglp.com/berberine-vs-semaglutide-honest-comparison) ### Mounjaro vs semaglutide: which is better? Query: mounjaro vs semaglutide which is better Mounjaro (tirzepatide) and semaglutide are both injectable medications used for weight management and blood sugar control, but they work differently and produce different averag... - [Mounjaro vs semaglutide: which is better?](https://blogs.sugarfitglp.com/mounjaro-vs-semaglutide-which-is-better) ### Ozempic vs Mounjaro in India 2026: Price, Results and Who Wins for Indians Query: ozempic vs mounjaro in india 2026 price results and who wins for indians If you have been researching weight loss or type 2 diabetes treatment in India, you have almost certainly come across two names: Ozempic and Mounjaro. Both are prescription medi... - [Ozempic vs Mounjaro in India 2026: Price, Results and Who Wins for Indians](https://blogs.sugarfitglp.com/ozempic-vs-mounjaro-in-india-2026-price-results-and-who-wins-for-indians) ### Semaglutide Price in India 2026: Generic vs Branded Ozempic Cost Breakdown Query: semaglutide price in india 2026 generic vs branded ozempic cost breakdown If you have been researching semaglutide for weight loss or type 2 diabetes management, you have likely noticed that the price varies enormously depending on the brand, dose, an... - [Semaglutide Price in India 2026: Generic vs Branded Ozempic Cost Breakdown](https://blogs.sugarfitglp.com/semaglutide-price-in-india-2026-generic-vs-branded-ozempic-cost-breakdown) ### Am I Eligible for GLP-1 in India? BMI, Conditions and Doctor Criteria Explained Query: Am I Eligible for GLP-1 in India? BMI, Conditions and Doctor Criteria Explained If you have heard about GLP-1 therapy for weight loss or blood sugar control and are wondering whether it applies to you, this guide explains the clinical criteria used in India... - [Am I Eligible for GLP-1 in India? BMI, Conditions and Doctor Criteria Explained](https://blogs.sugarfitglp.com/am-i-eligible-for-glp-1-in-india-bmi-conditions-and-doctor-criteria-explained) ### GLP-1 treatment in Tier 2 and Tier 3 cities in India: access and options Query: glp-1 treatment in tier 2 and tier 3 cities in india access and options For people living outside India's major metros, getting access to specialist-supervised weight loss treatment has historically meant long travel, long waits, or simply going wit... - [GLP-1 treatment in Tier 2 and Tier 3 cities in India: access and options](https://blogs.sugarfitglp.com/glp-1-treatment-in-tier-2-and-tier-3-cities-in-india-access-and-options)